Gestational trophoblastic disease: an overview

Area of Science:

• Obstetrics and Gynecology
• Reproductive Endocrinology
• Oncology

Background:

• Gestational trophoblastic disease (GTD) encompasses a spectrum of placental disorders.
• These conditions originate from abnormal placental trophoblastic development, ranging from benign molar pregnancies to malignant gestational trophoblastic neoplasm (GTN).

Purpose of the Study:

• To review the classification, symptomatology, diagnostic methods, and treatment options for GTD.
• To highlight the importance of midwife awareness regarding GTD incidence, risk factors, and symptoms for timely referral.
• To examine the psychosocial impact on affected women and discuss the midwife's role in management and follow-up.

Main Methods:

• Literature review of existing studies and clinical guidelines on GTD and GTN.
• Synthesis of information on disease entities, diagnostic modalities, and therapeutic interventions.
• Exploration of the psychosocial dimensions and the role of healthcare providers, particularly midwives.

Main Results:

• GTD includes molar pregnancy and malignant GTN, all stemming from abnormal placental development.
• Effective diagnosis relies on understanding varied symptomatology and utilizing appropriate diagnostic tools.
• Treatment strategies vary based on the specific GTD type, ranging from conservative management to chemotherapy.

Conclusions:

• Midwives play a vital role in early GTD detection and referral, despite management falling outside their direct scope.
• Comprehensive understanding of GTD, including psychosocial support, is essential for holistic patient care.
• Timely diagnosis and appropriate management are critical for improving outcomes in women with GTD and GTN.